October 16, 2021 : Issue #1170

TOP STORIES — Diabetes News and Research

Diabetes and COVID-19: Impact 18 Months into the Pandemic

Influence of Metformin Therapy on Mortality in COVID-19

Mortality and Cardiovascular Benefits of SGLT-2 Inhibitors in Type 2 Diabetes

Blood Sugar Fluctuations Lead to Poor Outcomes for Diabetes Patients with Coronavirus

Socioeconomic Status and Obesity in Patients with Diabetes

Hispanic/Latino Ethnicity Associated with Diabetes, Cognitive Decline, & Impairment

We are now 18 months into the pandemic, and many researchers have been able to look at data on the relationship of diabetes and the coronavirus.

This week, our team of interns have taken the time to find the latest information on how diabetes affects Covid outcomes (Laterpay feature), Covid’s effects on diabetes, and what diabetes medications might have a positive effect on Covid outcomes.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

Systemic review shows sex, age, comorbid conditions, insulin use, and several out-of-range lab predictors on hospital admission, all play a role in COVID-19 severity.

Glucose-lowering medication can influence COVID-19 pathogenesis and could have implications for treating patients with diabetes and COVID-19.

Are the mortality and cardiovascular benefits of SGLT-2 inhibitors limited to patients with type 2 diabetes who have established cardiovascular disease and renal disease?

Blood sugar levels of 70 to 160 mg/dL are considered normal, and anything outside these levels could negatively affect patients.

Are socioeconomic factors and obesity independently related to diabetes prevalence?

Long-term diabetes may lead to signs of cognitive decline in Latino patients as early as middle age.

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter:

Deonna Andrews, PharmD Candidate 2020 of Florida Agricultural & Mechanical University College of Pharmacy and Pharmaceutical Sciences 

Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences

Erica Hicks, PharmD Candidate 2022, South College School of Pharmacy

Oluwatayo Ishola, PharmD. Candidate, South College, School of Pharmacy

Emmanuella Louissaint, PharmD candidate, LECOM College of Pharmacy

Ding Nguyen, PharmD Candidate, University of South Florida Taneja College of Pharmacy

Your Friends in Diabetes Care
Steve and Dave

Diabetes In Control
www.diabetesincontrol.com